Four and a half LIM domains 1 (FHL1) and receptor interacting protein of 140 kDa (RIP140) interact and cooperate in estrogen signaling

International Journal of Biochemistry and Cell Biology

Volumn 41, Issue 7, 2009, Pages 1613-1618

  Lin, Jing ^a,b   Ding, Lihua ^a   Jin, Rui ^a   Zhang, Hao ^a   Cheng, Long ^a   Qin, Xi ^a   Chai, Jiake ^b   Ye, Qinong ^a  

^a BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Breast cancer; Estrogen signaling; FHL1; Interaction; RIP140; Transcriptional regulation

Indexed keywords

ESTROGEN; LIM PROTEIN; PROTEIN FHL1; PROTEIN PS2; RECEPTOR INTERACTING PROTEIN 140; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; GENE; GENE MAPPING; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; YEAST;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELL LINE, TUMOR; ESTROGENS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MUSCLE PROTEINS; NUCLEAR PROTEINS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TWO-HYBRID SYSTEM TECHNIQUES;

MAMMALIA;

EID: 63049086863     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2009.02.007     Document Type: Article

References (37)

1. Ali S., and Coombes R.C. Endocrine-responsive breast cancer and strategies for combating resistance. Nat Rev Cancer 2 (2002) 101-112
2. Augereau P., Badia E., Balaguer P., Carascossa S., Castet A., Jalaguier S., et al. Negative regulation of hormone signaling by RIP140. J Steroid Biochem Mol Biol 102 (2006) 51-59
3. Bai S., Kitaura H., Zhao H., Chen J., Müller J.M., Schüle R., et al. FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner. J Clin Invest 115 (2005) 2742-2751
4. Cavailles V., Dauvois S., Danielian P.S., and Parker M.G. Interaction of proteins with transcriptionally active estrogen receptors. Proc Natl Acad Sci USA 91 (1994) 10009-10013
5. Cavailles V., Dauvois S., L'Horst F., Lopez G., Hoare S., Kushner P.J., et al. Nuclear factor RIP 140 modulates transcriptional activation by the estrogen receptor. EMBO J 14 (1995) 3741-3751
6. Chan C.M., Lykkesfeldt A.E., Parker M.G., and Dowsett M. Expression of nuclear receptor interacting proteins TIF-1, SUG-1, receptor interacting protein 140, and corepressor SMRT in tamoxifen-resistant breast cancer. Clin Cancer Res 5 (1999) 3460-3467
7. Ding L., Yan J., Zhu J., Zhong H., Lu Q., Wang Z., et al. Ligand-independent activation of estrogen receptor α by XBP-1. Nucleic Acids Res 31 (2003) 5266-5274
8. Ding L., Wang Z., Yan J., Yang X., Liu A., Qiu W., et al. Human four-and-a-half LIM family members suppress tumor cell growth through a TGF-β-like signaling pathway. J Clin Invest 119 (2009) 349-361
9. Foster J.S., Henley D.C., Ahamed S., and Wimalasena J. Estrogens and cell-cycle regulation in breast cancer. Trends Endocrinol Metab 12 (2001) 320-327
10. Johannessen M., Moller S., Hansen T., Moens U., and van Ghelue M. The multifunctional roles of the four-and-a-half-LIM only protein FHL2. Cell Mol Life Sci 63 (2006) 268-284
11. Jordan V.C. Selective estrogen receptor modulation: concept and consequences in cancer. Cancer Cell 5 (2004) 207-213
12. Kadrmas J.L., and Beckerle M.C. The LIM domain: from the cytoskeleton to the nucleus. Nat Rev Mol Cell Biol 5 (2004) 920-931
13. Katzenellenbogen B.S., Montano M.M., Ekena K., Herman M.E., and McInerney E.M. Antiestrogens: mechanisms of action and resistance in breast cancer. Breast Cancer Res Treat 44 (1997) 23-38
14. Katzenellenbogen B.S., and Katzenellenbogen J.A. Estrogen receptor transcription and transactivation: estrogen receptor alpha and estrogen receptor beta: regulation by selective estrogen receptor modulators and importance in breast cancer. Breast Cancer Res 2 (2000) 335-344
15. Klinge C.M. Estrogen receptor interaction with co-activators and co-repressors. Steroids 65 (2000) 227-251
16. Lee S.M., Tsui S.K., Chan K.K., Garcia-Barcelo M., Waye M.M., Fung K.P., et al. Chromosomal mapping, tissue distribution and cDNA sequence of four-and-a-half LIM domain protein 1 (FHL1). Gene 216 (1998) 163-170
17. Leonardsson G., Steel J.H., Christian M., Pocock V., Milligan S., Bell J., et al. Nuclear receptor corepressor RIP140 regulates fat accumulation. Proc Natl Acad Sci USA 101 (2004) 8437-8442
18. Li X., Jia Z., Shen Y., Ichikawa H., Jarvik J., Nagele R.G., et al. Coordinate suppression of Sdpr and Fhl1 expression in tumors of the breast, kidney, and prostate. Cancer Sci 99 (2008) 1326-1333
19. Loughna P.T., Mason P., Bayol S., and Brownson C. The LIM domain protein FHL1 (SLIM 1) exhibits functional regulation in skeletal muscle. Mol Cell Biol Res Commun 3 (2000) 136-140
20. McGrath M.J., Mitchell C.A., Coghill I.D., Robinson P.A., and Brown S. Skeletal muscle LIM protein 1 (SLIM1/FHL1) induces alpha 5 beta 1-integrin-dependent myocyte elongation. Am J Physiol Cell Physiol 285 (2003) C1513-C1526
21. McGrath M.J., Cottle D.L., Nguyen M.A., Dyson J.M., Coghill I.D., Robinson P.A., et al. Four and a half LIM protein 1 binds myosin-binding protein C and regulates myosin filament formation and sarcomere assembly. J Biol Chem 281 (2006) 7666-7683
22. Powelka A.M., Seth A., Virbasius J.V., Kiskinis E., Nicoloro S.M., Guilherme A., et al. Suppression of oxidative metabolism and mitochondrial biogenesis by the transcriptional corepressor RIP140 in mouse adipocytes. J Clin Invest 116 (2006) 125-136
23. Qin H., Wang J., Liang Y., Taniguchi Y., Tanigaki K., and Han H. RING1 inhibits transactivation of RBP-J by Notch through interaction with LIM protein KyoT2. Nucleic Acids Res 32 (2004) 1492-1501
24. Qin H., Du D., Zhu Y., Li J., Feng L., Liang Y., et al. The PcG protein HPC2 inhibits RBP-J-mediated transcription by interacting with LIM protein KyoT2. FEBS Lett 579 (2005) 1220-1226
25. Quinzii C.M., Vu T.H., Min K.C., Tanji K., Barral S., Grewal R.P., et al. X-linked dominant scapuloperoneal myopathy is due to a mutation in the gene encoding four-and-a-half-LIM protein 1. Am J Hum Genet 82 (2008) 208-213
26. Robinson P.A., Brown S., McGrath M.J., Coghill I.D., Gurung R., and Mitchell C.A. Skeletal muscle LIM protein 1 regulates integrin-mediated myoblast adhesion, spreading, and migration. Am J Physiol Cell Physiol 284 (2003) C681-C695
27. Sakashita K., Mimori K., Tanaka F., Kamohara Y., Inoue H., Sawada T., et al. Clinical significance of loss of Fhl1 expression in human gastric cancer. Ann Surg Oncol 15 (2008) 2293-2300
28. Schessl J., Zou Y., McGrath M.J., Cowling B.S., Maiti B., Chin S.S., et al. Proteomic identification of FHL1 as the protein mutated in human reducing body myopathy. J Clin Invest 118 (2008) 904-912
29. Shen Y., Jia Z., Nagele R.G., Ichikawa H., and Goldberg G.S. SRC uses Cas to suppress Fhl1 in order to promote nonanchored growth and migration of tumor cells. Cancer Res 66 (2006) 1543-1552
30. Steel J.H., White R., and Parker M.G. Role of the RIP140 corepressor in ovulation and adipose biology. J Endocrinol 185 (2005) 1-9
31. Thenot S., Charpin M., Bonnet S., and Cavailles V. Estrogen receptor cofactors expression in breast and endometrial human cancer cells. Mol Cell Endocrinol 156 (1999) 85-93
32. White K.A., Yore M.M., Deng D., and Spinella M.J. Limiting effects of RIP140 in estrogen signaling. J Biol Chem 280 (2005) 7829-7835
33. White R., Leonardsson G., Rosewell I., Ann Jacobs M., Milligan S., and Parker M. The nuclear receptor co-repressor nrip1 (RIP140) is essential for female fertility. Nat Med 6 (2000) 1368-1374
34. White R., Morganstein D., Christian M., Seth A., Herzog B., and Parker M. Role of RIP140 in metabolic tissues: connections to disease. FEBS Lett 582 (2008) 39-45
35. Windpassinger C., Schoser B., Straub V., Hochmeister S., Noor A., Lohberger B., et al. An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1. Am J Hum Genet 82 (2008) 88-99
36. Yager J.D., and Davidson N.E. Estrogen carcinogenesis in breast cancer. N Engl J Med 354 (2006) 270-282
37. Zhang H., Xie X., Zhu X., Zhu J., Hao C., Lu Q., et al. Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells. J Biol Chem 280 (2005) 43188-43197